ArticleFrontiers in pharmacology2021

Efficacy of Conversion Surgery Following Apatinib Plus Paclitaxel/S1 for Advanced Gastric Cancer With Unresectable Factors: A Multicenter, Single-Arm, Phase II Trial.

Zhiyuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.